Alajangi HK, Kaur M, Sharma A et al (2022) Bloodbrain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders
Patients with neurological symptoms require more intensive treatment with alternate-day injections until improvement plateaus, and may need more frequent maintenance dosing
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinsons disease with motor fluctuations: a multicenter study
Subsequent bioinformatics analyses of DEPs included Gene Ontology (GO) functional annotation and enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis 1 , and protein-protein interaction (PPI) analysis via the STRING database
A GP or specialist can assess whether an individual's medical history, current medications, or underlying conditions make the use of a GLP-1/GIP/glucagon receptor agonist particularly risky
Compromised healing environments : Perhaps most intriguingly (and this is what catches my attention as a surgeon), BPC-157 appeared to promote healing even in situations where recovery was impaired, such as tissues affected by corticosteroid use or areas with very poor blood supply